Skip to Main Content

Paper Details

Plasma Soluble αKlotho, Serum Fibroblast Growth Factor 23, and Mobility Disability in Community-Dwelling Older Adults.
J Endocr Soc
4
2020
Adults, CKD, FGF23, Klotho, Mobility Disability, Participants, Plasma Soluble Klotho, Serum Fibroblast Growth Factor 23, Stair climb disability, Walking disability, chronic kidney disease, fibroblast growth factor 23, mobility disability, phosphate, plasma soluble Klotho, plasma-soluble Klotho, serum FGF23, stair climb disability, vitamin D, walking disability
Author NameAffiliation
Michelle ShardellInstitute for Genome Sciences, University of Maryland School of Medicine
Richard D SembaJohns Hopkins Medical Institutions
Tamara B HarrisNational Institute on Aging Intramural Research Program
Tamara B HarrisNational Institute on Aging Intramural Research Program
Peggy M CawthonResearch Institute, California Pacific Medical Center
Peggy M CawthonUniversity of California san francisco
Stephen B KritchevskySticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University
  • 1 - 7

Datasets

Release 1.2